Novartis AG EPS - Earnings per Share 2012-2026 | NVS

Novartis AG earnings per share (EPS) for the twelve months ending March 31, 2026 was $6.98, a 9.4% increase year-over-year.

  • Novartis AG EPS for the quarter ending March 31, 2026 was $1.65, a 9.34% decline year-over-year.
  • Novartis AG 2025 annual EPS was $7.15, a 21.81% increase from 2024.
  • Novartis AG 2024 annual EPS was $5.87, a 17.32% decline from 2023.
  • Novartis AG 2023 annual EPS was $7.1, a 123.97% increase from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Novartis AG EPS - Earnings per Share 2012-2026 | NVS

  • Novartis AG EPS for the quarter ending March 31, 2026 was $1.65, a 9.34% decline year-over-year.
  • Novartis AG 2025 annual EPS was $7.15, a 21.81% increase from 2024.
  • Novartis AG 2024 annual EPS was $5.87, a 17.32% decline from 2023.
  • Novartis AG 2023 annual EPS was $7.1, a 123.97% increase from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B